Tesamorelin 10mg
Tesamorelin is a lab-grade GHRH analog designed to deliver clean, repeatable growth-hormone (GH) pulses in cell-based and rodent models. By mimicking your body’s natural GHRH but resisting rapid breakdown, Tesamorelin injections enable precise studies of fat-metabolism, IGF-1 activation, and endocrine-feedback loops. Each 10 mg vial is USA-manufactured under ISO standards, HPLC-verified to ≥ 99% purity, and endotoxin-screened (< 0.1 EU/mg).
⚠️ Important Disclaimer
For Research Use Only. Not for human consumption or therapeutic treatment.
Tesamorelin
KEY HIGHLIGHTS
Controlled GH Pulses for Metabolic Studies
Tesamorelin peptide reliably triggers GH peaks within 30–60 minutes, giving you tight temporal control to measure downstream IGF-1 and lipolytic markers in adipocyte and muscle assays.
Fat-Metabolism & Lipolysis Modeling
In differentiated adipocyte cultures, Tesamorelin boosts hormone-sensitive lipase (HSL) activity and free-fatty-acid release—empowering labs to dissect lipid-oxidation pathways and evaluate anti-obesity interventions.
IGF-1 Pathway Engagement
GH pulses from Tesamorelin lead to consistent IGF-1 upregulation in hepatocyte and myoblast models, creating a robust platform to study anabolic signaling, protein synthesis, and cell-growth dynamics.
Body-Composition Insights
Rodent dosing regimens with Tesamorelin show measurable reductions in visceral-fat indices and improvements in lean-mass markers—ideal for preclinical obesity, cachexia, or metabolic-syndrome research.
Endocrine-Feedback Loop Dissection
Tesamorelin’s half-life (~ 60 minutes) allows repeated dosing without receptor desensitization, giving researchers clear windows to probe somatostatin and GH-release hormone feedback mechanisms.
Once-Weekly Micro-Dose Convenience
Lyophilized Tesamorelin dissolves cleanly in sterile or bacteriostatic water, yielding a stable solution for up to 7 days at 2–8 °C. This simplifies multi-day studies and ensures ≥ 98% peptide integrity.
What Is Tesamorelin Peptide?
Tesamorelin is a synthetic, 44-amino-acid peptide analog of human growth-hormone releasing hormone (GHRH). Engineered for enhanced stability, it resists enzymatic degradation to produce predictable, short-duration GH pulses that mimic natural endocrine rhythms. In research, Tesamorelin peptide is used to investigate how GH influences fat breakdown, muscle anabolism, and IGF-1-mediated cell signaling—all without the prolonged half-life or off-target effects of other secretagogues.
Why Choose Tesamorelin?
Researchers choose Tesamorelin when they require precise control over growth-hormone release to model metabolic and endocrine pathways without confounding variables. Tesamorelin injections deliver robust, short-lived GH surges that align closely with physiological pulses, enabling clear measurement of downstream effects on lipolysis and IGF-1 production. Produced in ISO-certified facilities and verified to ≥ 99% purity with stringent endotoxin screening, Tesamorelin ensures data consistency across both in vitro and in vivo studies. Whether your focus is adipocyte metabolism, lean-mass regulation, or pituitary feedback loops, Tesamorelin’s reproducible performance and straightforward handling make it an essential reagent for high-impact research.
What Sets Tesamorelin Apart?
Tesamorelin stands out from other GH-releasing agents by combining potent receptor engagement with a half-life optimized for research applications. Its 44-residue design enhances stability just enough to generate clean GH peaks—yet clears rapidly to avoid receptor desensitization or off-target hormone elevations such as cortisol or prolactin. This unique pharmacokinetic profile allows researchers to dissect GH-IGF-1-lipolysis pathways with unprecedented temporal resolution. From high-throughput cell assays to longitudinal rodent models, Tesamorelin’s proven reliability and minimal hormonal “noise” set a new standard for GH-axis and metabolic-health studies.
Tesamorelin FAQs
What is Tesamorelin peptide used for?
To model GH release, fat breakdown, and IGF-1 signaling in cell and animal research settings.
How does Tesamorelin trigger GH release?
It binds pituitary GHRH receptors to induce predictable GH pulses of ~ 30–60 minutes.
What benefits does Tesamorelin show in fat-cell assays?
Increases hormone-sensitive lipase activity and free-fatty-acid release for lipolysis modeling.
What dose of Tesamorelin is typical in vitro?
Concentrations range from 100 nM to 1 µM, adjusted per cell type and endpoint.
How is Tesamorelin reconstituted?
Dissolve in Sterile Water for Injection or Bacteriostatic Water, mix gently, and use immediately or store at 2–8 °C.
What storage conditions are required?
Store lyophilized vials at – 20 °C; use reconstituted peptide within 7 days at 2–8 °C.
Does Tesamorelin affect other hormones?
No significant cortisol or prolactin elevation—data reflect GH-specific effects only.
Can Tesamorelin be combined with other peptides?
Yes, it’s often co-studied with secretagogues like Ipamorelin or CJC-1295 for synergistic GH-axis modulation.
Is Tesamorelin approved for therapeutic use?
No—Tesamorelin is strictly for research use only, not for clinical or veterinary applications.
Where can I buy Tesamorelin injections?
Real Peptides offers ISO-certified, USA-manufactured Tesamorelin (10 mg), ≥ 99% purity, and low endotoxin—available for research use only.